Delivery Order SPE2DB24D2205-SPE2DB25FDTGP

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $4,470.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. This delivery order was placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,655.64, is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,546.46 firm-fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply DESCOVY 200-25 MG TABLET in a quantity of 30s. The contract, valued at $6,556.47, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $3,956.17 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $2,937.60 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DESCOVY 200-25 MG TABLET medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract has an award value of $13,484.11 and is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,394.82 fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,107.35 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET medication, with a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DESCOVY 200-25 MG TABLET UU 30S. The contract is a firm-fixed-price delivery order with a ceiling value of $6,481.91 and a completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTGP
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides $54,796.74 for the delivery of DESCOVY 200-25 MG TABLET UU 30S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award has a Firm Fixed Price pricing type and an ultimate completion date of October 29, 2024. The contract does not have a set-aside designation, indicating open competition.

Generated 2/2/25, 12:07 AM